{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:39:44Z","timestamp":1767202784140,"version":"build-2238731810"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical phenotypic overlap between frontotemporal dementia (FTD) and Alzheimer\u2019s disease (AD) frequently leads to misdiagnosis, while biomarkers (e.g., A\u03b2-PET) and genetic testing provide critical differential diagnostic evidence. Although MAPT gene mutations represent common genetic etiologies of FTD, their occurrence in Asian populations remains underreported. Specifically, FTD caused by the MAPT IVS10 + 16C&amp;gt;T mutation shows limited documentation in Asian populations, with its phenotypic heterogeneity and treatment responses remaining poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a case of FTD manifesting progressive memory decline, compulsive behaviors, and apathy. MRI revealed bilateral frontoparietotemporal atrophy with prominent medial temporal lobe and hippocampal involvement, initially misdiagnosed as AD. Subsequent A\u03b2-PET negativity emerged as a pivotal diagnostic turning point, and identification of a heterozygous MAPT mutation (IVS10 + 16C&amp;gt;T) confirmed behavioral variant FTD (bvFTD) diagnosis. Partial improvement in compulsive behaviors and verbal fluency was observed following memantine treatment. A literature review summarizes clinical characteristics of FTD associated with IVS10 + 16C&amp;gt;T mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comprehensive neuropsychological assessment, cranial MRI, and negative A\u03b2-PET excluded AD pathology. Genetic confirmation of MAPT IVS10 + 16C&amp;gt;T mutation established bvFTD diagnosis. Three-month memantine treatment reduced compulsive behaviors without cognitive improvement. Literature analysis indicates this mutation\u2019s rarity in Asian populations, typically presenting with behavioral abnormalities frequently misdiagnosed as AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study rectified misdiagnosis of MAPT IVS10 + 16C&amp;gt;T-associated bvFTD through multimodal diagnostics, emphasizing the synergistic value of genetic testing and neuroimaging. Memantine\u2019s partial behavioral symptom alleviation suggests potential mutation-specific therapeutic efficacy requiring further validation. Future directions should optimize diagnostic protocols (e.g., cost-effective genetic screening) and address barriers to early diagnosis in Asian populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1645068","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:10:19Z","timestamp":1763417419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MAPT mutation-induced behavioral variant frontotemporal dementia in an Asian patient: a multimodal biomarker case report resolving diagnostic challenges with Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Amina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong\u2019an","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia. The lund and Manchester groups","volume":"57","year":"1994","journal-title":"J. Neurology, Neurosurg. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(12)70320-4","article-title":"Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Boxer","year":"2013","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.3","article-title":"Specification of synaptic connectivity by cell surface interactions","volume":"17","author":"De Wit","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/archneur.64.10.1535","article-title":"Familial early-onset dementia with tau intron 10 + 16 mutation with clinical features similar to those of Alzheimer disease","volume":"64","author":"Doran","year":"2007","journal-title":"Arch. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J. Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1176\/appi.neuropsych.21060166","article-title":"Advances in treatment of frontotemporal dementia","volume":"34","author":"Guimet","year":"2022","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1007\/s00415-024-12528-5","article-title":"Frontotemporal lobar degeneration in the \u201cAnnual of the Pathological Autopsy Cases in Japan\u201d","volume":"271","author":"Horimoto","year":"2024","journal-title":"J. Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/wnl.58.8.1161","article-title":"Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation","volume":"58","author":"Janssen","year":"2002","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/21678421.2021.1880596","article-title":"Genetics of frontotemporal dementia in China","volume":"22","author":"Jiang","year":"2021","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/WAD.0b013e3181664ea4","article-title":"Mutation negative \u201cearly-onset familial Alzheimer disease\u201d: consider screening for tau gene mutations","volume":"22","author":"Larner","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jns.2009.08.063","article-title":"Intrafamilial clinical phenotypic heterogeneity with MAPT gene splice site IVS10+16C>T mutation","volume":"287","author":"Larner","year":"","journal-title":"J. Neurological Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1371\/journal.pmed.1000019","article-title":"A 50-year-old man with deteriorating cognitive function and impaired movement","volume":"6","author":"Larner","year":"","journal-title":"PLoS Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/s1041610221001630","article-title":"404 - factors associated with diagnostic delay in younger-onset dementia iagnostic delay in younger-onset dementia","volume":"33","author":"Loi","year":"2021","journal-title":"Int. Psychogeriatrics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"Cd003154","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","volume":"3","author":"Mcshane","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1212\/01.wnl.0000072325.27824.a5","article-title":"Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP","volume":"61","author":"Morris","year":"2003","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awf069","article-title":"Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene","volume":"125","author":"Pickering-Brown","year":"2002","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1017\/S104161021200213X","article-title":"Cross-cultural differences in dementia: the sociocultural health belief model","volume":"25","author":"Sayegh","year":"2013","journal-title":"Int. Psychogeriatrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00415-004-0489-x","article-title":"Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies","volume":"251","author":"Stanford","year":"2004","journal-title":"J. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","article-title":"Fluid biomarkers in frontotemporal dementia: past, present and future","volume":"92","author":"Swift","year":"2021","journal-title":"J. Neurology, Neurosurg. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3233\/JAD-2010-101632","article-title":"Memantine in behavioral variant frontotemporal dementia: negative results","volume":"23","author":"Vercelletto","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1002\/alz.14215","article-title":"Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia","volume":"20","author":"Xu","year":"2024","journal-title":"Alzheimer's Dementia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1212\/WNL.0000000000012410","article-title":"Characterizing the clinical features and atrophy patterns of MAPT-related frontotemporal dementia with disease progression modeling","volume":"97","author":"Young","year":"2021","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1017\/S1041610215000940","article-title":"Delayed help seeking behavior in dementia care: preliminary findings from the clinical pathway for alzheimer's disease in China (CPAD) study","volume":"28","author":"Zhao","year":"2016","journal-title":"Int. Psychogeriatrics"}],"updated-by":[{"DOI":"10.3389\/fgene.2025.1749030","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1645068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:40:34Z","timestamp":1764556834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1645068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":25,"alternative-id":["10.3389\/fgene.2025.1645068"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1645068","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1645068"}}